Gelonghui, November 20th, Huayang Asia Vets (301502.SZ) stated in recent investor relations activities that, first of all, the company's product functionality, user experience, etc. are basically no different from foreign-funded enterprises. Compared to foreign companies, the company has advantages in terms of development cost, development time cycle, and customer customization. Secondly, foreign-funded enterprises mainly use mechanical injection pens for mass market applications, while the company's core product electronic injection pen has been maturely applied in the field of growth hormone, providing customers with more choices.
华阳智能(301502.SZ)：核心产品电子注射笔已在生长激素等领域成熟应用
Huayang Asia Vets (301502.SZ): Core product electronic injection pens have been maturely applied in areas such as growth hormone.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha